This news article has expired. Below you will find a short description about the news article and comments that were left by CancerCompass users.
Combining two chemotherapy drugs with trastuzumab (Herceptin) to treat women who have metastatic HER2+ breast cancer may offer physicians another choice in their treatment options.
We care about your feedback. Let us know how we can improve your CancerCompass experience.